Course book Advanced Treatment Planning 2018

Parameters for clinical outcome: Salivary glands

NTCP dose-response models evaluation for analysis of parotid gland function:

50%

NTCP

19.4%

25 Gy

TD50: 39.4 Gy

EUD [Gy]

Houweling AC et al. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int. J. Radiation Oncology Biol. Phys., Vol. 76, No. 4, pp. 1259–1265, 2010.